Medical artificial intelligence (AI) company Lunit (CEO Seo Beom-seok) announced on the 11th that it had been selected as a supplier for a breast cancer diagnosis AI solution bid by UniHA, a French public hospital purchasing cooperative.
Uniha is France's largest public health purchasing cooperative, responsible for medical device procurement for over 1,500 public hospitals and 130 regional hospital associations. This tender was for the joint purchase of an AI solution for breast cancer screening among its member hospitals.
Through this contract, Lunit will supply its mammography AI solution 'Lunit Insight MMG', 3D breast tomography AI solution 'Lunit Insight DBT', as well as its subsidiary Volpara's mammography image quality management solution 'Volpara Analytics' and real-time image quality feedback solution 'Volpara Live'. Accordingly, Uniha member hospitals will be able to introduce Lunit Group's solutions through Fujifilm, a global medical imaging equipment manufacturer, without a separate bidding process.
“We conducted a tender with rigorous technical criteria in response to the growing demand for mammography AI solutions from our member institutions,” said Bertrand Lepage, head of the Uniha Biomedical Program. “Our goal is to enable public health institutions to adopt the highest level of technology on equal terms with private hospitals.”
Seo Beom-seok, CEO of Lunit, said, “This contract has secured an opportunity to supply large-scale AI solutions to public hospitals across France. The long-term collaboration with Fujifilm and selection through competitive bidding are achievements that demonstrate Lunit-Volpara’s technological prowess in the field of breast cancer screening, and will serve as an opportunity to strengthen our position in the European public market.”
Meanwhile, Eric Kamus, a radiologist at Lille University Hospital, a member hospital of Uniha in France who is using the Lunit AI solution, said, “Lunit AI is a reliable tool that helps medical staff maintain high concentration and accuracy despite their long clinical experience.”
- See more related articles
You must be logged in to post a comment.